Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Depreciation & Amortization (CF) (2019 - 2025)

Neurogene (NGNE) has disclosed Depreciation & Amortization (CF) for 4 consecutive years, with $797000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (CF) changed 0.38% year-over-year to $797000.0, compared with a TTM value of $3.1 million through Sep 2025, up 28.36%, and an annual FY2024 reading of $3.2 million, down 3.03% over the prior year.
  • Depreciation & Amortization (CF) was $797000.0 for Q3 2025 at Neurogene, down from $803000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $815000.0 in Q2 2024 and bottomed at $700000.0 in Q1 2025.